SI
Therapeutic Areas
92Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NTB-928 | Solid Tumors (FRα+) | Pre-clinical |
| CD123 x γδ T-cell Engager | Acute Myeloid Leukemia (AML) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| NTB-928 | Solid Tumors (FRα+) | Pre-clinical |
| CD123 x γδ T-cell Engager | Acute Myeloid Leukemia (AML) | Pre-clinical |